|
PRINT ISSN : 2319-7692
Online ISSN : 2319-7706 Issues : 12 per year Publisher : Excellent Publishers Email : editorijcmas@gmail.com / submit@ijcmas.com Editor-in-chief: Dr.M.Prakash Index Copernicus ICV 2018: 95.39 NAAS RATING 2020: 5.38 |
Thalassemia is an autosomal recessive disease causing haemolytic anaemia. The ideal treatment of these patients involves regular, 2-4 weekly blood transfusions. The major complications by this treatment are the transmission of transfusion acquired infections such as Hepatitis B virus infection, Hepatitis C virus infection, Human immunodeficiency virus infection, Syphilis, Malaria and transfusion acquired iron overload. Aim of the study is to evaluate the prevalence of Hepatitis B & C among Thalassemic patients transmitted by blood transfusion. Retrospective study was conducted in Microbiology department, Shri M.P. Shah medical college and GGG hospital, Jamnagar from January 2016 to June 2017. Patients with thalassaemia having regular blood transfusions at this hospital were enrolled. 200 serum samples were tested by using ELISA Kits for HBsAg and Anti HCV. Out of 200 patients 119(59.5%) were male and 81(40.5%) were females. Out of them 02(1%) HBsAg positive and 10(5%) Anti–HCV reactive. More sensitive screening tests, stringent donor selection and vaccinating all children at the time of induction into the thalassemia transfusion programme are required for the better control of this transfusion – transmitted infections among Thalassemia patients.